Description
Screening assessment to exclude innate (hereditary) metabolic "errors" such as aminoacidopathies and fatty acid beta-oxidation disorders. Indicated for newborns in the first weeks of life after the start of breastfeeding or formula feeding.
Period of execution
Within 6 days. The specified time does not include the day of biomaterial collection
Biomaterial type